Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systematic study of tissue factor expression in solid tumors.
de Bono JS, Harris JR, Burm SM, Vanderstichele A, Houtkamp MA, Aarass S, Riisnaes R, Figueiredo I, Nava Rodrigues D, Christova R, Olbrecht S, Niessen HWM, Ruuls SR, Schuurhuis DH, Lammerts van Bueren JJ, Breij ECW, Vergote I. de Bono JS, et al. Among authors: harris jr. Cancer Rep (Hoboken). 2023 Feb;6(2):e1699. doi: 10.1002/cnr2.1699. Epub 2022 Aug 13. Cancer Rep (Hoboken). 2023. PMID: 36806722 Free PMC article.
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.
Hong DS, Concin N, Vergote I, de Bono JS, Slomovitz BM, Drew Y, Arkenau HT, Machiels JP, Spicer JF, Jones R, Forster MD, Cornez N, Gennigens C, Johnson ML, Thistlethwaite FC, Rangwala RA, Ghatta S, Windfeld K, Harris JR, Lassen UN, Coleman RL. Hong DS, et al. Among authors: harris jr. Clin Cancer Res. 2020 Mar 15;26(6):1220-1228. doi: 10.1158/1078-0432.CCR-19-2962. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796521 Clinical Trial.
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I; innovaTV 204/GOG-3023/ENGOT-cx6 Collaborators. Coleman RL, et al. Among authors: harris jr. Lancet Oncol. 2021 May;22(5):609-619. doi: 10.1016/S1470-2045(21)00056-5. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845034 Clinical Trial.
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study.
Yonemori K, Kuboki Y, Hasegawa K, Iwata T, Kato H, Takehara K, Hirashima Y, Kato H, Passey C, Buchbjerg JK, Harris JR, Andreassen CM, Nicacio L, Soumaoro I, Fujiwara K. Yonemori K, et al. Among authors: harris jr. Cancer Sci. 2022 Aug;113(8):2788-2797. doi: 10.1111/cas.15443. Epub 2022 Jun 15. Cancer Sci. 2022. PMID: 35633184 Free PMC article. Clinical Trial.
Stigma among ebola disease survivors in Mubende and Kassanda districts, Central Uganda, 2022.
Zalwango MG, Paige S, Migisha R, Nakafeero Simbwa B, Nsubuga EJ, Asio A, Kabami Z, Zalwango JF, Kawungezi PC, Wanyana MW, King P, Naiga HN, Agaba B, Zavuga R, Earle-Richardson G, Kwesiga B, Bulage L, Kadobera D, Ario AR, Harris JR. Zalwango MG, et al. Among authors: harris jr. PLOS Glob Public Health. 2024 Dec 16;4(12):e0003272. doi: 10.1371/journal.pgph.0003272. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39680556 Free PMC article.
Participant engagement and involvement in longitudinal cohort studies: qualitative insights from a selection of pregnancy and birth, twin, and family-based population cohort studies.
Budin-Ljøsne I, Fredheim NAG, Jevne CA, Kleven BM, Charles MA, Felix JF, Flaig R, García MP, Havdahl A, Islam S, Kerr SM, Meder IK, Molloy L, Morton SMB, Pizzi C, Rahman A, Willemsen G, Wood D, Harris JR. Budin-Ljøsne I, et al. Among authors: harris jr. BMC Med Res Methodol. 2024 Dec 3;24(1):297. doi: 10.1186/s12874-024-02419-8. BMC Med Res Methodol. 2024. PMID: 39623293 Free PMC article.
Surgical Predictors of Clinical Outcome 6 Years After Revision ACL Reconstruction.
MARS Group; Wright RW, Huston LJ, Haas AK, Pennings JS, Allen CR, Cooper DE, DeBerardino TM, Dunn WR, Lantz BBA, Spindler KP, Stuart MJ, Amendola AN, Annunziata CC, Arciero RA, Bach BR Jr, Baker CL 3rd, Bartolozzi AR, Baumgarten KM, Berg JH, Bernas GA, Brockmeier SF, Brophy RH, Bush-Joseph CA, Butler JB 5th, Carey JL, Carpenter JE, Cole BJ, Cooper JM, Cox CL, Creighton RA, David TS, Flanigan DC, Frederick RW, Ganley TJ, Gatt CJ Jr, Gecha SR, Giffin JR, Hame SL, Hannafin JA, Harner CD, Harris NL Jr, Hechtman KS, Hershman EB, Hoellrich RG, Johnson DC, Johnson TS, Jones MH, Kaeding CC, Kamath GV, Klootwyk TE, Levy BA, Ma CB, Maiers GP 2nd, Marx RG, Matava MJ, Mathien GM, McAllister DR, McCarty EC, McCormack RG, Miller BS, Nissen CW, O'Neill DF, Owens BD, Parker RD, Purnell ML, Ramappa AJ, Rauh MA, Rettig AC, Sekiya JK, Shea KG, Sherman OH, Slauterbeck JR, Smith MV, Spang JT, Svoboda SJ, Taft TN, Tenuta JJ, Tingstad EM, Vidal AF, Viskontas DG, White RA, Williams JS Jr, Wolcott ML, Wolf BR, York JJ. MARS Group, et al. Among authors: harris nl jr. Am J Sports Med. 2024 Nov;52(13):3286-3294. doi: 10.1177/03635465241288227. Am J Sports Med. 2024. PMID: 39503722
1,909 results